AMRI signs definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals
AMRI today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals, Inc. for $38.2 million in cash.